Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
<p>Abstract</p> <p>Previously, we have successfully targeted the mannose receptor (MR) expressed on monocyte-derived dendritic cells (DCs) using a fully human MR-specific antibody, B11, as a vehicle to deliver whole protein tumor antigens such as the human chorionic gonadotropin ho...
Main Authors: | Berger Marc A, Tario Joseph D, Vasilakos John P, Ramakrishna Venky, Wallace Paul K, Keler Tibor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-01-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/5/1/5 |
Similar Items
-
The Role of Toll-like Receptors in Immune Responses Mediated by Human Dendritic Cell Subsets
by: Duraisingham, Sai Suda
Published: (2010) -
Systems-Level Analysis of the Toll-like Receptor Network of Dendritic Cells
by: Chevrier, Nicolas
Published: (2012) -
Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
by: Kai Naumann, et al.
Published: (2013-01-01) -
Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands
by: Kornbluth Richard S, et al.
Published: (2009-08-01) -
Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
by: Misako Matsumoto, et al.
Published: (2017-12-01)